Literature DB >> 3407766

Histamine stimulation of prostaglandin and HETE synthesis in human endothelial cells.

G E Revtyak1, M J Hughes, A R Johnson, W B Campbell.   

Abstract

Endothelial cells (EC) cultured from human umbilical artery (UA) and vein (UV) metabolized [14C]arachidonic acid to prostaglandins (PGs), monohydroxyeicosatetraenoic acids (HETEs), and epoxyeicosatrienoic acids (EETs). Major radioactive products were identified as 6-keto-PGF1 alpha, PGE2, PGF2 alpha, 12-hydroxy heptadecatrienoic acid, 15-HETE, and 11-HETE. In addition, extracts from UV ECs contained 12-HETE, 5-HETE, 14,15-EET, and 5,6-EET as minor products, whereas extracts from UA ECs contained only 12-HETE as a minor product. UA ECs also produced metabolites comigrating with 14,15-EET, 11,12-EET, 8,9-EET, and 5,6-EET. Histamine increased the release of [14C]PGs and [14C]HETEs from [14C]arachidonic acid-labeled ECs. Indomethacin, aspirin, and nordihydroguauretic acid completely inhibited synthesis of both [14C]PGs and [14C]HETEs from exogenous [14C]arachidonic acid in these cells. Microsomes metabolized [14C]arachidonic acid to the same [14C]PGs and [14C]HETEs as intact cells. Pretreatment of microsomes with indomethacin completely inhibited formation of these products. These data indicate that UA ECs and UV ECs metabolize endogenous and exogenous arachidonic acid to both PGs and HETEs. Also 15-HETE and 11-HETE appear to be synthesized by a microsomal enzyme with the properties of cyclooxygenase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3407766     DOI: 10.1152/ajpcell.1988.255.2.C214

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  Endothelium-derived hyperpolarising factors and associated pathways: a synopsis.

Authors:  Gillian Edwards; Michel Félétou; Arthur H Weston
Journal:  Pflugers Arch       Date:  2010-04-11       Impact factor: 3.657

2.  Interleukin-1 beta-induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine.

Authors:  S D Bamforth; S L Lightman; J Greenwood
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

3.  Atherogenic concentrations of low-density lipoprotein enhance endothelial cell generation of epoxyeicosatrienoic acid products.

Authors:  K A Pritchard; P Y Wong; M B Stemerman
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

4.  Synthesis and release of platelet-activating factor and eicosanoids in human endothelial cells induced by different agonists.

Authors:  F Cabré; D Tost; N Suesa; M Gutiérrez; P Ucedo; D Mauleón; G Carganico
Journal:  Agents Actions       Date:  1993-03

5.  Release of 15-hydroxy-5,8,11,13-eicosatetraenoic acid and cysteinyl-leukotrienes in carrageenin-induced inflammation: effect of non-steroidal anti-inflammatory drugs.

Authors:  B M Peskar; M Trautmann; P Nowak; B A Peskar
Journal:  Agents Actions       Date:  1991-07

6.  Synthesis of arachidonic acid metabolites by Syrian hamster platelets and peritoneal cells.

Authors:  M E Surette; J Whelan; G P Lu; J E Kinsella
Journal:  Lipids       Date:  1993-12       Impact factor: 1.880

7.  GPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells.

Authors:  Sang-Kyu Park; Anja Herrnreiter; Sandra L Pfister; Kathryn M Gauthier; Benjamin A Falck; John R Falck; William B Campbell
Journal:  J Biol Chem       Date:  2018-05-18       Impact factor: 5.157

8.  Relative roles of nitric oxide and cyclo-oxygenase and lipoxygenase products of arachidonic acid in the contractile responses of rat renal arcuate arteries.

Authors:  X C Wu; N T Richards; J Michael; E Johns
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

9.  Interdependence of contractile responses of rat small mesenteric arteries on nitric oxide and cyclo-oxygenase and lipoxygenase products of arachidonic acid.

Authors:  X C Wu; E Johns; J Michael; N T Richards
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

10.  PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.

Authors:  Lujin Wu; Wei Wang; Meiyan Dai; Huihui Li; Chen Chen; Daowen Wang
Journal:  BMC Cancer       Date:  2019-12-02       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.